A vaccine against the coronavirus pandemic by CureVac could be on the market in mid-2021, the unlisted German company said on Wednesday.
CureVac might be able to apply for approval early next year, Klaus Cichutek, president of German vaccine regulator PEI, added during a joint videoconference.